AVANIR Pharmaceuticals (AVNR)

Add to Watchlists
Create an Alert
3.49 +0.02  +0.58% NASDAQ Apr 24, 8:00PM BATS Real time Currency in USD
View Full Chart
AVNR Price Chart
View All Events

AVNR Events

Date Type Description
Feb 12 Misc AGM Event for Avanir Pharmaceuticals
Feb 05 Misc AVANIR Pharmaceuticals Q1 2014 Earnings Conference Call
Feb 05 Earnings AVANIR Pharmaceuticals Q1 2014 Earnings Results. Estimate: -0.08.
Dec 10 Misc AVANIR Pharmaceuticals Announces Date of Fiscal 2013 Fourth Quarter Financial Results and Conference Call
Dec 10 Earnings Avanir Pharmaceuticals Announces Date of Fiscal 2013 Fourth Quarter Financial Results. Estimate: -0.06.
Oct 29 Misc AVANIR Pharmaceuticals Investor Day
Aug 06 Misc Q3 2013 AVANIR Pharmaceuticals Earnings Conference Call
Aug 06 Earnings Fiscal 2013 Third Quarter Financial Results. Estimate: -0.06.
Jul 02 Misc AVANIR/optinose License Agreement Conference Call
May 08 Misc Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
View All Performance Charts

AVNR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AVANIR Pharmaceuticals is up 13.31% over the last year vs S&P 500 Total Return up 21.54%, Lannett up 238.3%, and Furiex Pharmaceuticals up 146.7%.

Get Quote for

PDF Report for AVNR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download AVNR Pro Report PDF

Portfolio Strategies Featuring AVNR

Did AVANIR Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AVNR Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: September 30, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: September 30, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Avanir Pharmaceuticals is a biopharmaceutical company engaged in acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders.

Recent Quotes

Symbol Price Chg Chg % Market Cap
AVNR 3.49 +0.02 +0.58% 531.51M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.